期刊文献+

冬凌草对非酒精性脂肪肝大鼠模型的治疗作用 被引量:1

Efficacy of Rabdosia rubescens on rats with non-alcoholic fatty liver disease
原文传递
导出
摘要 目的探讨冬凌草对非酒精性脂肪性肝病(NAFLD)大鼠血清生化指标和肝组织过氧化物酶体增殖剂激活受体(PPAR)α和PPARγ表达的影响。方法采用高脂饲料喂养的SD雄性大鼠构建NAFLD模型,随机分正常组、模型组、多烯磷脂酰胆碱组、冬凌草低、中和高剂量组,每组6只。HE染色观察大鼠肝组织脂肪变性程度;采用全自动生化仪测定生物化学指标;采用硫代巴比妥酸(TBA)法测定丙二醛(MDA)含量;采用黄嘌呤氧化酶法测定超氧化物歧化酶(SOD)活力;采用分光光度法测定谷胱甘肽过氧化物酶(GSH-Px)活力;提取肝组织采用免疫组织化学和RT-PCR测定各组大鼠肝组织PPARα、PPARγ蛋白和mRNA的表达。结果与模型组比较,冬凌草能降低ALT、AST活性和减少血清胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-H)的含量,升高高密度脂蛋白(HDL-C)的含量,调节血脂,显著增加肝组织SOD和GSH-Px活性,降低MDA含量(P均<0.05)。与正常组相比,模型组PPARα和PPARγ蛋白表达(6.95±4.45和2.73±1.07)及mRNA(0.36±0.02和0.21±0.02)明显减少(P<0.05),冬凌草低、中和高剂量组与模型组相比,PPARα、PPARγ蛋白及mRNA表达增多,并且呈剂量依赖性(P<0.05)。结论冬凌草对大鼠血清的生化指标和肝组织有良好的改善作用,这可能与其抗氧化、上调PPARα和PPARγ的表达有关。 Objective To investigate the effects of Rabdosia rubescens on the serum levels of biochemical markers and the expressions of peroxisome proliferator-activated receptors(PPAR)αandγin liver tissues of rats with non-alcoholic fatty liver disease(NAFLD).Methods The male SD rat models of NAFLD were established by high-fat diets.The rats were randomly divided into six groups,including normal group,model group,polyene phosphatidylcholine(Yishanfu)group,and Rabdosia rubescens low-dose,medium-dose and high-dose groups with 6 rats in each group.The degree of steatosis in liver tissues of rats was observed by HE staining.The biochemical parameters were measured by automatic biochemical analyzer.Malondialdehyde(MDA)was determined by thiobarbituric acid(TBA),superoxide dismutase(SOD)activity was determined by xanthione oxidase(XOD),and glutathione peroxidase(GSH-PX)activity was determined by spectrophotometry.The expressions of PPARα,PPARγprotein and mRNA in liver tissues of rats in each group were determined by immunohistochemistry and RT-PCR methods.Results Compared with the model group,Rabdosia rubescens reduced the activity of ALT and AST,decreased serum levels of total cholesterol(TC),total triglyceride(TG)and low-density lipoprotein cholesterol(LDL-C),and increased the level of high-density lipoprotein cholesterol(HDL-C)(P all<0.05).In addition,It regulated blood lipids,significantly increased the activity of SOD and GSH-Px of liver tissues,and reduced the MDA content(P all<0.05).Compared with the normal group,the expressions of PPARαand PPARγprotein(6.95±4.45 and 2.73±1.07)and mRNA(0.36±0.02 and 0.21±0.02)significantly decreased in the model group(P<0.05).Compared with the model group,the expressions of PPARαand PPARγprotein and mRNA increased in a dose-dependent manner in the Rabdosia rubescens low-dose,medium-dose and high-dose groups(P<0.05).Conclusions Rabdosia rubescens is effective in improving serum biochemical markers and liver tissues in rats,and it may be related to its anti-oxidation,up-regulatio
作者 马文骏 史婷婷 琚立萍 白明辉 陈小伟 蔡兆斌 Ma Wenjun;Shi Tingting;Ju Liping;Bai Minghui;Chen Xiaowei;Cai Zhaobin(Department of Infectious Diseases,the Xixi Hospital of Zhejiang Chinese Medical University,Hangzhou 310023,China)
出处 《国际流行病学传染病学杂志》 CAS 2020年第3期217-222,共6页 International Journal of Epidemiology and Infectious Disease
关键词 冬凌草属 非酒精性脂肪肝病 过氧化物酶体增殖剂激活受体 生化指标 Rabdosia Non-alcoholic fatty liver disease PPAR Biochemical parameters
  • 相关文献

参考文献5

二级参考文献33

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):43-48. 被引量:470
  • 2Carmine Finelli,Giovanni Tarantino.What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?[J].World Journal of Gastroenterology,2013,19(6):802-812. 被引量:30
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 4陈思文,陈岳祥,张兴荣,曾欣,刘苏,谢渭芬.牛磺酸对大鼠实验性脂肪肝的防治作用[J].中华肝脏病杂志,2006,14(3):226-227. 被引量:11
  • 5Marko Duvnjak,Ivan Leroti,Neven Bari,Vedran Tomai,Lucija Virovi Juki,Vedran Velagi.Pathogenesis and management issues for non-alcoholic fatty liver disease[J].World Journal of Gastroenterology,2007,13(34):4539-4550. 被引量:75
  • 6Christopher D. Williams,Joel Stengel,Michael I. Asike,Dawn M. Torres,Janet Shaw,Maricela Contreras,Cristy L. Landt,Stephen A. Harrison.Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study[J]. Gastroenterology . 2011 (1) 被引量:5
  • 7Manuelpillai Ursula,Tchongue Jorge,Lourensz Dinushka,Vaghjiani Vijesh,Samuel Chrishan S,Liu Alison,Williams Elizabeth D,Sievert William.Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl?-treated mice. Cell Transplantation . 2010 被引量:2
  • 8Marianne Schmidt,Christine Polednik,Jeanette Roller,Rudolf Hagen.Cytotoxicity of herbal extracts used for treatment of prostatic diseaseon head and neck carcinoma cell lines and non-malignant primary mucosal cells[J]. Oncology Reports . 2013 (2) 被引量:1
  • 9Xu Liu,Wei-Guang Wang,Xue Du,Xiao-Nian Li,Ling-Mei Kong,Yan Li,Jian-Xin Pu,Ji-Zhou Wu,Han-Dong Sun.Enmein-type diterpenoids from the aerial parts of Isodon rubescens and their cytotoxicity[J]. Fitoterapia . 2012 (8) 被引量:1
  • 10Ruby L.C. Hoo,Ida P.C. Lee,Mi Zhou,Janice Y.L. Wong,Xiaoyan Hui,Aimin Xu,Karen S.L. Lam.Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice[J]. Journal of Hepatology . 2012 被引量:1

共引文献24

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部